Sedoanalgesia with remifentanil in definitive pacemaker implant;Sedoanalgesia con remifentanilo en el implante de marcapasos definitivo

Medicina Intensiva

Volumn 30, Issue 8, 2006, Pages 370-373

  Blancas Gomez Casero R ^a   Martin Delgado C ^a   Nevado Losada, E ^a   Quintana Diaz M ^b   Chana Garcia M ^a   Lopez Matamala B ^a   Serrano Castaneda J ^a   Gonzalez Manzanares J L ^a  

^a HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^b HOSPITAL NUESTRA SEÑORA DEL PRADO   (Spain)

Author keywords

Analgesia; Definitive pacemaker; Remifentanil; Sedation

Indexed keywords

DIPYRONE; MAGNESIUM; MEPIVACAINE; METOCLOPRAMIDE; REMIFENTANIL;

ADULT; AGED; ANALGESIA; ARTICLE; ARTIFICIAL HEART PACEMAKER; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; RATING SCALE; RESPIRATION DEPRESSION; SEDATION; VOMITING;

EID: 33845286484     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(06)74550-8     Document Type: Article

References (10)

1. Ramsay MA, Savege TN, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2:656-9.
2. Muellejans B, López A, Cross MH, Bonome C, Morrison L, Kirham AJT. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial. Critical Care. 2004;8:1-12.
3. Karabinis A, Mandragos K, Stergiopoulos S, Komnos A, Spokup J, Speelberg B, et al. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial. Critical Care. 2004;8:268-80.
4. Lehmann A, Lang J, Thaler E, Zeitler C, Weisse U, Boldt J. Considerations in patients undergoing implantation of a biventricular pacemaker. J Cardiothorac Vasc Anesth. 2002;16: 175-9.
5. Lehmann A, Boldt J, Zeitler C, Thaler E, Werling C. Total intravenous anesthesia with remifentanil and propofol for implantation of cardioverter-defibrillators in patients with severely reduced left ventricula function. J Cardiothorac Vasc Anesth. 1999;13:15-9.
6. Muñoz T, Poveda Y, Dudagoitia JL, Martínez S, Vibuesa C, Hernández M, et al. Comparación de onda monofásica y bifásica en la cardioversión eléctrica de la fibrilación auricular. Med Intensiva. 2005;29:79-82.
7. Muñoz T, Castedo JF, Castañeda A, Dudagoitia JL, Poveda Y, Iribarren S. Cardioversión eléctrica bajo anestesia con bolus único de propofol y remifentanilo. Fhoros. 2002;1:7-11.
8. Tipps LB, Coplin WM, Murry KR, Rhoney DH. Safety and feasibility of continuous infusion of remifentanil in the neurosurgical intensive care. Neurosurgery. 2000;46:596-601.
9. Glass PSA, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg. 1999;89:S7-14.
10. Castañeda J. Farmacocinética y farmacodinámica del remifentanilo. Med Intensiva. 2003;Supl 1:10-3.